NASH-TAG 2021
March 11-13, 2021
To help you get as much value from NASH-TAG 2021 as possible, we have identified several presentations and articles we find most interesting. Our daily podcasts will summarize these and discuss what they suggest for the future of NASH/NAFLD therapies.
Advanced Notification
S2-E2 – A Deeper Dive Into Fatty Liver, NAFLD, and NASH
In this episode of the Rising Tide series for frontline professionals, the patients themselves and caregivers, co-hosts Ken Cusi and Roger Green are joined by KOL in hepatology, Manal Abdelmalek and KOL in endocrinology, Scott Isaacs for a deeper dive into Fatty Liver, NAFLD and NASH. The group discusses: morbidities and mortalities related to fatty liver disease, paradigm-shifting data, screening for risk stratification, pediatric and adolescent populations, unique key takeaways and much more.
S4-12 – Deep Dive: ICER Draft Report on Resmetirom and Obeticholic Acid for NASH
The Surfers evaluate a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH. This high-caliber session offers a plethora of practical considerations around accessing approved NASH pharmacotherapies for those most in need.
S4-11.6 – From the Vault: #NASHDay 2022 Preview: SurfingNASH Predictions
Jörn Schattenberg, Louise Campbell, Stephen Harrison and Roger Green share “SurfingNASH predictions” of the most important events that will take place between the 5th and 6th International NASH Days.
S4-11.5 – Excitement and Trepidations: Exploring the Year Ahead in Fatty Liver
This final segment with Jeff McIntyre of the Global Liver Institute (GLI) wraps up discussion around what’s happening in NAFLD and NASH for the first quarter of an exciting year. Roger Green invites the panelists to provide the most significant and optimistic thing they will be touching over the next three months followed by the greatest fear each has in the same space.
S4-11.4 – Increasing Incidence of Type-2 Diabetes Among Adolescents
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking discussion on increasing incidence of Type-2 diabetes among adolescents. The group shares ideas around what’s contributing to this swelling burden and how to dampen its devastating impact.
S4-11.3 – Fighting for Fair Regulation Around What’s Deemed “Healthy”
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking session around bringing hepatology to the public health dinner table. This conversation explores what’s going on in the assessment of package nutrition labeling and fighting for fair regulation around what’s deemed “healthy.”
